Cargando…

Octarellin VI: Using Rosetta to Design a Putative Artificial (β/α)(8) Protein

The computational protein design protocol Rosetta has been applied successfully to a wide variety of protein engineering problems. Here the aim was to test its ability to design de novo a protein adopting the TIM-barrel fold, whose formation requires about twice as many residues as in the largest pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Figueroa, Maximiliano, Oliveira, Nicolas, Lejeune, Annabelle, Kaufmann, Kristian W., Dorr, Brent M., Matagne, André, Martial, Joseph A., Meiler, Jens, Van de Weerdt, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747059/
https://www.ncbi.nlm.nih.gov/pubmed/23977165
http://dx.doi.org/10.1371/journal.pone.0071858
_version_ 1782280855995023360
author Figueroa, Maximiliano
Oliveira, Nicolas
Lejeune, Annabelle
Kaufmann, Kristian W.
Dorr, Brent M.
Matagne, André
Martial, Joseph A.
Meiler, Jens
Van de Weerdt, Cécile
author_facet Figueroa, Maximiliano
Oliveira, Nicolas
Lejeune, Annabelle
Kaufmann, Kristian W.
Dorr, Brent M.
Matagne, André
Martial, Joseph A.
Meiler, Jens
Van de Weerdt, Cécile
author_sort Figueroa, Maximiliano
collection PubMed
description The computational protein design protocol Rosetta has been applied successfully to a wide variety of protein engineering problems. Here the aim was to test its ability to design de novo a protein adopting the TIM-barrel fold, whose formation requires about twice as many residues as in the largest proteins successfully designed de novo to date. The designed protein, Octarellin VI, contains 216 residues. Its amino acid composition is similar to that of natural TIM-barrel proteins. When produced and purified, it showed a far-UV circular dichroism spectrum characteristic of folded proteins, with α-helical and β-sheet secondary structure. Its stable tertiary structure was confirmed by both tryptophan fluorescence and circular dichroism in the near UV. It proved heat stable up to 70°C. Dynamic light scattering experiments revealed a unique population of particles averaging 4 nm in diameter, in good agreement with our model. Although these data suggest the successful creation of an artificial α/β protein of more than 200 amino acids, Octarellin VI shows an apparent noncooperative chemical unfolding and low solubility.
format Online
Article
Text
id pubmed-3747059
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37470592013-08-23 Octarellin VI: Using Rosetta to Design a Putative Artificial (β/α)(8) Protein Figueroa, Maximiliano Oliveira, Nicolas Lejeune, Annabelle Kaufmann, Kristian W. Dorr, Brent M. Matagne, André Martial, Joseph A. Meiler, Jens Van de Weerdt, Cécile PLoS One Research Article The computational protein design protocol Rosetta has been applied successfully to a wide variety of protein engineering problems. Here the aim was to test its ability to design de novo a protein adopting the TIM-barrel fold, whose formation requires about twice as many residues as in the largest proteins successfully designed de novo to date. The designed protein, Octarellin VI, contains 216 residues. Its amino acid composition is similar to that of natural TIM-barrel proteins. When produced and purified, it showed a far-UV circular dichroism spectrum characteristic of folded proteins, with α-helical and β-sheet secondary structure. Its stable tertiary structure was confirmed by both tryptophan fluorescence and circular dichroism in the near UV. It proved heat stable up to 70°C. Dynamic light scattering experiments revealed a unique population of particles averaging 4 nm in diameter, in good agreement with our model. Although these data suggest the successful creation of an artificial α/β protein of more than 200 amino acids, Octarellin VI shows an apparent noncooperative chemical unfolding and low solubility. Public Library of Science 2013-08-19 /pmc/articles/PMC3747059/ /pubmed/23977165 http://dx.doi.org/10.1371/journal.pone.0071858 Text en © 2013 Figueroa et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Figueroa, Maximiliano
Oliveira, Nicolas
Lejeune, Annabelle
Kaufmann, Kristian W.
Dorr, Brent M.
Matagne, André
Martial, Joseph A.
Meiler, Jens
Van de Weerdt, Cécile
Octarellin VI: Using Rosetta to Design a Putative Artificial (β/α)(8) Protein
title Octarellin VI: Using Rosetta to Design a Putative Artificial (β/α)(8) Protein
title_full Octarellin VI: Using Rosetta to Design a Putative Artificial (β/α)(8) Protein
title_fullStr Octarellin VI: Using Rosetta to Design a Putative Artificial (β/α)(8) Protein
title_full_unstemmed Octarellin VI: Using Rosetta to Design a Putative Artificial (β/α)(8) Protein
title_short Octarellin VI: Using Rosetta to Design a Putative Artificial (β/α)(8) Protein
title_sort octarellin vi: using rosetta to design a putative artificial (β/α)(8) protein
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747059/
https://www.ncbi.nlm.nih.gov/pubmed/23977165
http://dx.doi.org/10.1371/journal.pone.0071858
work_keys_str_mv AT figueroamaximiliano octarellinviusingrosettatodesignaputativeartificialba8protein
AT oliveiranicolas octarellinviusingrosettatodesignaputativeartificialba8protein
AT lejeuneannabelle octarellinviusingrosettatodesignaputativeartificialba8protein
AT kaufmannkristianw octarellinviusingrosettatodesignaputativeartificialba8protein
AT dorrbrentm octarellinviusingrosettatodesignaputativeartificialba8protein
AT matagneandre octarellinviusingrosettatodesignaputativeartificialba8protein
AT martialjosepha octarellinviusingrosettatodesignaputativeartificialba8protein
AT meilerjens octarellinviusingrosettatodesignaputativeartificialba8protein
AT vandeweerdtcecile octarellinviusingrosettatodesignaputativeartificialba8protein